Search Results - "Torregrosa, Josep V"

Cinacalcet in the management of normocalcaemic secondary hyperparathyroidism after kidney transplantation: one-year follow-up multicentre study by Torregrosa, Josep V, Morales, Enrique, Díaz, Juan M, Crespo, Josep, Bravo, Juan, Gómez, Gonzalo, Gentil, Miguel A, Rodríguez-Benot, Alberto, Rodríguez-García, Minerva, López-Jiménez, Verónica, Gutiérrez-Dalmau, Álex, Jimeno, Luisa, Pérez-Sáez, M José, Romero, Rafael, Gómez-Alamillo, Carlos

“…The effect of cinacalcet in patients with persistent secondary hyperparathyroidism (SHPT) after kidney transplantation (RT) has mainly been reported in…”
Get more information

Skeletal muscle mitochondrial function is preserved in young patients with chronic renal failure by Miró, Òscar, Marrades, Ramon M., Roca, Josep, Sala, Ernest, Masanés, Ferran, Campistol, Josep M., Torregrosa, Josep V., Casademont, Jordi, Wagner, Peter D., Cardellach, Francesc

“…Patients with chronic renal failure (CRF) show limited exercise tolerance, classically attributed to anemia. However, persistence of abnormally low peak oxygen…”
Get full text

Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure by Marrades, R M, Roca, J, Campistol, J M, Diaz, O, Barberá, J A, Torregrosa, J V, Masclans, J R, Cobos, A, Rodríguez-Roisin, R, Wagner, P D

“…Erythropoietin (rHuEPO) has proven to be effective in the treatment of anemia of chronic renal failure (CRF). Despite improving the quality of life, peak…”
Get full text

Cellular bioenergetics after erythropoietin therapy in chronic renal failure by Marrades, R M, Alonso, J, Roca, J, González de Suso, J M, Campistol, J M, Barberá, J A, Diaz, O, Torregrosa, J V, Masclans, J R, Rodríguez-Roisin, R, Wagner, P D

“…After erythropoietin (rHuEPO) therapy, patients with chronic renal failure (CRF) do not improve peak O2 uptake (VO2 peak) as much as expected from the rise in…”
Get full text